ProfileGDS4718 / 219819_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 83% 75% 73% 71% 73% 85% 89% 79% 72% 81% 84% 66% 87% 88% 88% 81% 81% 90% 86% 69% 80% 78% 82% 82% 82% 88% 75% 83% 79% 79% 78% 80% 62% 78% 89% 81% 86% 75% 76% 78% 82% 86% 78% 89% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.2862783
GSM549102patient 115, normal, homogenized [OPG study]7.2243975
GSM549104patient 119, normal, homogenized [OPG study]7.204573
GSM549108patient 138, normal, homogenized [OPG study]6.9287271
GSM549119patient 077, normal, homogenized [OPG study]7.1047773
GSM549133patient 032, cancer, homogenized [OPG study]8.5560885
GSM549139patient 042, cancer, homogenized [OPG study]8.9561989
GSM549099patient 107, normal, homogenized [OPG study]7.6719579
GSM549109patient 139, normal, homogenized [OPG study]7.0066172
GSM549110patient 046, normal, homogenized [OPG study]7.9330881
GSM549114patient 063, normal, homogenized [OPG study]8.4671384
GSM549122patient 082, normal, homogenized [OPG study]6.5873866
GSM549134patient 033, cancer, homogenized [OPG study]8.7854987
GSM549136patient 036, cancer, homogenized [OPG study]8.9985688
GSM549140patient 044, cancer, homogenized [OPG study]8.9294588
GSM549111patient 047, normal, homogenized [OPG study]7.9887481
GSM549113patient 057, normal, homogenized [OPG study]8.0855381
GSM549132patient 031, cancer, homogenized [OPG study]9.1986690
GSM549137patient 038, cancer, homogenized [OPG study]8.5380386
GSM549142patient 047, cancer, homogenized [OPG study]6.7609169
GSM549100patient 110, normal, homogenized [OPG study]7.7924680
GSM549107patient 135, normal, homogenized [OPG study]7.662878
GSM549115patient 068, normal, homogenized [OPG study]8.1829582
GSM549116patient 072, normal, homogenized [OPG study]8.1326682
GSM549120patient 078, normal, homogenized [OPG study]8.0694182
GSM549131patient 030, cancer, homogenized [OPG study]9.0097488
GSM549118patient 074, normal, homogenized [OPG study]7.3536175
GSM549129patient 027, cancer, homogenized [OPG study]8.1650783
GSM549123patient 088, normal, homogenized [OPG study]7.7588279
GSM549124patient 006, cancer, homogenized [OPG study]7.6883479
GSM549126patient 015, cancer, homogenized [OPG study]7.6801178
GSM549128patient 025, cancer, homogenized [OPG study]7.954980
GSM549103patient 117, normal, homogenized [OPG study]6.2465262
GSM549117patient 073, normal, homogenized [OPG study]7.6425278
GSM549138patient 041, cancer, homogenized [OPG study]9.0122789
GSM549141patient 045, cancer, homogenized [OPG study]8.076881
GSM549130patient 028, cancer, homogenized [OPG study]8.4748186
GSM549101patient 111, normal, homogenized [OPG study]7.3200975
GSM549105patient 128, normal, homogenized [OPG study]7.377576
GSM549106patient 134, normal, homogenized [OPG study]7.737778
GSM549112patient 048, normal, homogenized [OPG study]8.1349882
GSM549125patient 011, cancer, homogenized [OPG study]8.600686
GSM549127patient 024, cancer, homogenized [OPG study]7.7042378
GSM549135patient 035, cancer, homogenized [OPG study]9.1082189